Virtu Financial’s Nautilus Biotechnolgy NAUT Stock Holding History

Virtu Financial’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$93K	Buy	+49,943	New	+$132K	﹤0.01%	1125
2026 Q1	–	Sell	-23,532	Closed	-$46K	–	2062
2025 Q4	$46K	Buy	23,532 +3,849	+20%	+$6.31K	﹤0.01%	1317
2025 Q3	$17K	Buy	+19,683	New	+$14.5K	﹤0.01%	1297
2025 Q1	–	Sell	-16,604	Closed	-$28K	–	1798
2024 Q4	$28K	Buy	+16,604	New	+$39.7K	﹤0.01%	1247
2024 Q1	–	Sell	-26,337	Closed	-$79K	–	1852
2023 Q4	$79K	Buy	+26,337	New	+$75.4K	0.01%	1077
2022 Q1	–	Sell	-25,495	Closed	-$132K	–	1834
2021 Q4	$132K	Buy	+25,495	New	+$136K	0.01%	1001

Other funds holding NAUT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Virtu Financial's NAUT Position: Q2 2026 in Review

Virtu Financial opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 49,943 shares worth $93K. The stake represents ﹤0.01% of the portfolio and ranks #1125 among its holdings. This is a return to the name: Virtu Financial previously reported a position in NAUT as recently as Q4 2025.

Virtu Financial first reported a position in NAUT in Q4 2021 and has held it in 6 quarters since. The position peaked at $132K in Q4 2021. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

Virtu Financial held 49,943 shares of Nautilus Biotechnolgy worth $93K as of Q2 2026.
Nautilus Biotechnolgy was a new Virtu Financial position in Q2 2026.
Nautilus Biotechnolgy made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1125 holding.
Virtu Financial first reported a position in Nautilus Biotechnolgy in Q4 2021 and has held it in 6 quarters since.
Virtu Financial's Nautilus Biotechnolgy position peaked at $132K in Q4 2021.
93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.